Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)

Clinical trial NCT07744698 · RECRUITING

Trial details

NCT number: NCT07744698
Sponsor: Anhui Provincial Cancer Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Squamous Non-Small Cell Lung Cancer sqNSCLC Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Start date: 2026-07-24
Primary completion: 2029-06-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.